Nature's contribution to today's pharmacopeia

Lin Tao,Feng Zhu,Chu Qin,Cheng Zhang,Feng Xu,Chun Yan Tan,Yu Yang Jiang,Yu Zong Chen
DOI: https://doi.org/10.1038/nbt.3034
IF: 46.9
2014-01-01
Nature Biotechnology
Abstract:To the Editor Two decades after mainstream drug discovery shifted its focus away from bioprospecting and natural products (NPs)1, a systematic survey of new molecular entities (NMEs) approved by the US Food and Drug Administration (FDA) indicates that NPs still make a substantial contribution to today's new drugs2, 3. For the… Download references
What problem does this paper attempt to address?